Načítá se...
New Medications for Heart Failure
Heart failure is common and results in substantial morbidity and mortality. Current guideline-based therapies for heart failure with reduced ejection fraction, including beta-blockers, angiotensin converting enzyme (ACE) inhibitors, and aldosterone antagonists aim to interrupt deleterious neurohormo...
Uloženo v:
| Vydáno v: | Trends Cardiovasc Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4958495/ https://ncbi.nlm.nih.gov/pubmed/27038558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tcm.2016.02.008 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|